Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAD001 in Advanced Thyroid Cancer
NCT01164176Phase 2Completed
- Sponsor
- Yonsei University
- Start
- Mar 2010
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in thyroid cancer, sponsored by Yonsei University. Started Mar 2010; status: completed.
02
Drugs
everolimus
03
Conditions
thyroid cancer
Beyond the preview
Go deeper on NCT01164176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01164176.